Lucia Pirvu

Dr. Lucia Pirvu

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2020 in Chemical Biology & Drug Design
Verified
Journal Article
Closed access
PDF file
Ranjan K. MohapatraRanjan K. Mohapatra
Ranjan K. Mohapatra
Lucia PintilieLucia Pintilie
Lucia Pintilie
VKVenkataramana Kandi
Venkataramana Kandi
ASAshish Kumar Sarangi
Ashish Kumar Sarangi
DDDebadutta Das
Debadutta Das
LPLina Perekhoda
Lina Perekhoda

1 March 2021 in Journal of King Saud University – Science
Verified
Journal Article
Open access
RMRanjan K. Mohapatra
Ranjan K. Mohapatra
LPLina Perekhoda
Lina Perekhoda
MAMohammad Azam
Mohammad Azam
MSMarharyta Suleiman
Marharyta Suleiman
ASAshish K. Sarangi
Ashish K. Sarangi
SASaud I. Al-Resayes
Saud I. Al-Resayes
In this study, we examined five previously synthesized compounds and checked their binding affinity towards the SARS-CoV-2 main protease (Mpro) by molecular docking study, and compared the data with three FDA approved drugs, i.e., Remdesivir, Ivermectine and Hydroxychlorochine. In addition, we have investigated the docking study against the main protease of SARS-CoV-2 (Mpro) by using Autodock 4.2 software package. The results suggested that the investigated compounds have property to bind the active position of the protein as reported in approved drugs. Hence, further experimental studies are required. The formation of intermolecular interactions, negative values of scoring functions, free binding energy and the calculated binding constants confirmed that the studied compounds have significant affinity for the specified biotarget. These studied compounds were passed the drug-likeness criteria as suggested by calculating ADME data by SwissADME server. Moreover, the ADMET properties suggested that the investigated compounds to be orally active compounds in human. Furthermore, density functional computations (DFT) were executed by applying GAUSSIAN 09 suit program. In addition, Quantitative Structure-Activity Relationship (QSAR) was studied by applying HyperChem Professional 8.0.3 program.

23 May 2020 in Applied Organometallic Chemistry
Verified
Journal Article
Closed access
PDF file
ASAshish Kumar Sarangi
Ashish Kumar Sarangi
BMBipin Bihari Mahapatra
Bipin Bihari Mahapatra
Ranjan K. MohapatraRanjan K. Mohapatra
Ranjan K. Mohapatra
SSSisir Kumar Sethy
Sisir Kumar Sethy
DDDebadutta Das
Debadutta Das
HMHemanta Meher
Hemanta Meher

1 April 2021 in Journal of Molecular Structure
Verified
Journal Article
Closed access
TATaghreed H. Al-Noor
Taghreed H. Al-Noor
RMRanjan K. Mohapatra
Ranjan K. Mohapatra
MAMohammad Azam
Mohammad Azam
LKLekaa K. Abdul Karem
Lekaa K. Abdul Karem
PMPranab K. Mohapatra
Pranab K. Mohapatra
Lucia PintilieLucia Pintilie
Lucia Pintilie

6 May 2020 in Journal of Saudi Chemical Society
Verified
Journal Article
Open access
PDF file
NENajla M. El-Barasi
Najla M. El-Barasi
MMMiloud M. Miloud
Miloud M. Miloud
MEMarei M. El-Ajaily
Marei M. El-Ajaily
Ranjan K. MohapatraRanjan K. Mohapatra
Ranjan K. Mohapatra
ASAshish Kumar Sarangi
Ashish Kumar Sarangi
MAMohammad Azam
Mohammad Azam
A novel series of three trivalent mononuclear ternary complexes of the type, [ML1L2] [M = Cr(III), Fe(III) and La(III), HL1 = 2-((2-(2,4-dinitrophenyl)hydrazone)methyl)phenol, HL2 = 2-aminophenol] was investigated by various physio-chemical studies. To obtain additional information inside the structure, density functional theory calculation was also carried out. The synthesized complexes showed remarkable antimicrobial activity when tested against A. niger, A. flavus, R. stolonifer, C. albicans, E. coli and Klebsiella sp. microbes. Furthermore, the molecular docking analysis was also carried out to analyze the interactions in protein–ligand complexes. Moreover, the quantitative structure–activity relationship was also investigated to study the biological activity of the ligand.

25 March 2020 in Molecules
Verified
Journal Article
Open access
PDF file
CLCarmen Limban
Carmen Limban
Carmen ChifiriucCarmen Chifiriuc
Carmen Chifiriuc
MCMiron T. Caproiu
Miron T. Caproiu
FDFlorea Dumitrascu
Florea Dumitrascu
MFMarilena Ferbinteanu
Marilena Ferbinteanu
Diana Camelia NutaDiana Camelia Nuta
Diana Camelia Nuta
The increasing threat of antimicrobial resistance to all currently available therapeutic agents has urged the development of novel antimicrobials. In this context, a series of new benzoylthiourea derivatives substituted with one or more fluorine atoms and with the trifluoromethyl group have been tested, synthesized, and characterized by IR, NMR, CHNS and crystal X-ray diffraction. The molecular docking has provided information regarding the binding affinity and the orientation of the new compounds to Escherichia coli DNA gyrase B. The docking score predicted the antimicrobial activity of the studied compounds, especially against E. coli, which was further demonstrated experimentally against planktonic and biofilm embedded bacterial and fungal cells. The compounds bearing one fluorine atom on the phenyl ring have shown the best antibacterial effect, while those with three fluorine atoms exhibited the most intensive antifungal activity. All tested compounds exhibited antibiofilm activity, correlated with the trifluoromethyl substituent, most favorable in para position.